Search Results
Results found for "Luke Pattison"
- đ° GPCR Weekly News, May 15 to 21, 2023
If you are interested in giving a talk, contact us at Hello@DrGPCR.com, and if you would like to present
- Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR
the evolutionary conservation of these residues can lead to the development of drugs that are less likely
- The Truth About GPCR Product Launches: Years in the Making
GPCR X Revvity Collaboration ⸝ Want more like this? đ Join the Dr.
- đ° GPCR Weekly News, October 23 to 29, 2023
cell mobilization when combined with propranolol Discovery of 3-Phenyl Indazole-Based Novel Chemokine-like
- How a Failed Med School Dream Sparked a GPCR Biotech Revolution
that slow down or prevent good science from reaching patients â particularly in underfunded fields like
- Understanding the Journey: Catherine Demery's Path to Addiction Science
excelling in the PCAT and gaining admission to pharmacy school at the University of Michigan, it seemed like
- Interacting binding insights and conformational consequences of the differential activity of...
contrast, when the GPR55 receptor is simulated in complex with the selective agonist ML186, agonist-like
- When January Looks Different by March: Orthosteric vs. Allosteric Insights from Our Latest AMA
Screening liabilities early Integrating chemistry insights immediately Avoiding advancement of scaffolds likely
- Self-docking and cross-docking simulations of G protein-coupled receptor-ligand complexes
conformational sampling in advance of docking or receptor conformational adjustment after docking are more likely
- đ° GPCR Weekly News, April 1 to 7, 2024
If you have any research you would like to showcase to our community, you can submit a poster presentation
- Orthosteric vs. Allosteric Interactions: The Silent Decider of Safety and Success
Allosterics , in contrast, act more like tuning knobsâmodulating receptor ensembles in partnership with
- Targeting GPCRs in the CNS: Advances in Drug Discovery Strategies
Depending on the type of GPCR, it can lead to different secondary messengers , like cAMP, IP3, which
- Why Opposing Processes Matter for Your Next GPCR Drug
The same compound can look like an activator in one system and a blocker in anotherâdepending on basal
- How Advanced GPCR Kinetics Sharpen Decision Making (and Save You Time)
Gives You an Edge Premium delivers curated, noise-free intelligence every week: expert frameworks  (like
- Mechanism vs. Assumption: A Model-First Path to Getting GPCR MoA Right
practical guidance on TR-FRET compatibility, photobleaching resistance, and 3D stack acquisition for tissue-like
- Fentanyl and Xylazine: Why Breathing Fails in Overdose
First responders describe revivals that donât feel like revivals, as if the body is still trapped in
- Artificial intelligence â faster, smarter, cheaper GPCR drug discovery
Efforts will likely be made to develop AI models that can provide transparent explanations for their The sharing and collaboration of data across academia, industry, and regulatory bodies will likely increase
- đ° GPCR Buzz: August 5-11, 2024 | Top Highlights from DrGPCR University!
protein signalling and modulates excitability of human induced pluripotent stem cell-derived nociceptive-like
- đ° GPCR Weekly News, January 16 to 22, 2023
Revealing the tissue-level complexity of endogenous glucagon-like peptide-1 receptor expression and signaling
- đ° GPCR Weekly News, June 5 to 11, 2023
Before we dive into this weekâs news, weâd like to draw your attention to some of our events and resources
- How to Avoid the Most Common Gaps in Your Biotech Pitch
. â Start with relevance, not results. 2ď¸âŁ Using buzzwords instead of clarity Words like âplatformâ,
- Extracellular signal-regulated kinases â a potential pathway for GPCR-targeted drug discovery
Initially, the activation of small GTPases like RAS leads to the activation of the MAP kinase kinase
- đ° GPCR Weekly News, February 13 to 19, 2023
If you'd like to suggest papers to include in our news, please email them to us at Hello@DrGPCR.com.
- đ° GPCR Weekly News, November 6 to November 12, 2023
in Cardiology, Endocrinology, and Taste Lack of HCAR1, the lactate GPCR, signaling promotes autistic-like
- GPCR Collaboration: From Models to Medicine
The most effective discovery programs are structured like Carlssonâs: modeling designed with downstream
- Beyond Clearance: The Strategic Power of Irreversible Drug Binding
When these drugs hit structured tissues (like solid tumors), they can get trapped at the periphery, leaving
- đ° GPCR Weekly News, July 24 to July 30, 2023
Lukas Grätz, David Gloriam, and Gunnar Schulteâs research on Unveiling pathway selectivity in Frizzleds
- Discover the Hottest GPCR News of the Week: Oct 7-13, 2024!
Let's make your brand shine like never before!
- đ° GPCR Weekly News, April 3 to 9, 2023
The program is under construction but if youâd like to give a talk or present a poster, email us at Hello
- Drug Discovery Pharmacology Principles That Turn Assays Into Real Medicines
tissues or proteins One classic example occurs when compounds dissolve poorly, behaving essentially like

















